Wells Fargo Upgrades RxSight Inc. (RXST) to Overweight

Wells Fargo analyst Lawrence Biegelsen upgraded RxSight Inc. (NASDAQ: RXST) from Equal Weight to Overweight with a price target of $42.00.

For an analyst ratings summary and ratings history on RxSight Inc. click here. For more ratings news on RxSight Inc. click here.

Shares of RxSight Inc. closed at $37.53 yesterday.

You May Also Be Interested In

• Macquarie Upgrades Broadcom Limited (AVGO) to Outperform
• Fox Advisors Upgrades Dell (DELL) to Overweight
• Deutsche Bank Upgrades Sirius XM Radio (SIRI) to Buy, 'mispriced based on a large disconnect between consensus estimates and what we believe the company can achieve